SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotime-Nasdaq's best kept secret?
BTIM 0.00010000.0%Nov 5 1:26 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stephen How who wrote (1043)7/2/1998 4:43:00 PM
From: Jim Roof  Read Replies (1) of 1432
 
<<What's the point of your question?
<Steve awaits the personal attack.> >>

No personal attack coming. I just read your post and from it alone I was unsure of what your point is. Biotime may indeed consider that albumin is superior to their product but it is my understanding that it is extremely expensive and as a natural product is subject to potential contamination. The figures that I have heard run well into the multiple hundreds of dollars per liter.

<<They think that albumin + electrolytes + buffer + [another optional HES or Dextran] is a better solution than Hextend>>

Again, that may well be. I would also assume that those who are involved in bona fide blood substitutes would not consider their products to be superior to blood itself. I do not find this at all troublesome or alarming. The real question is not Hextend vs. albumin as we all know.

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext